IP Library › Granted Patent US 11,542,465
Granted Patent B2
US 11,542,465 · App. 16/462,047 · Granted Jan 3, 2023

Microfluidic system and method of use thereof

Inventors: Scott Noggle (New York, NY); Stephen Chang (New York, NY)
Assignee: New York Stem Cell Foundation, Inc.
C12M47/04B01L3/5027F16K99/0003G01N15/02F16K2099/0086G01N2015/0065G01N2015/1006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,542,465
App. No.
16/462,047
Granted
Jan 3, 2023
Kind
B2
Abstract

This invention concerns an integrated microfluidic system that utilizes microfluidic chip technology to receive a patient sample including cells, expand the cells, reprogram the expanded cells and then store the reprogrammed cells in a microfluidic chip. These microfluidic chips with stored reprogrammed cells may then be used in scenarios of genetic differentiation into specific cell types. Overall this system and workflow is suitable as a hospital based device that will allow the generation of iPSCs from every patient for downstream diagnostic or therapeutic use.

Claims (27)

1. A microfluidic system for processing a biological sample comprising

a) one or more microfluidic units to process the sample, the processing comprising:

i) isolating cells from the sample to produce an isolated population of cells;

ii) expanding the isolated population of cells to produce a population of expanded cells;

iii) reprogramming the population of isolated cells or the population of expanded cells; and

iv) storing cells from one or more of (i), (ii) or (iii); and

b) one or more computer memory modules containing instructions, and programmed for controlling one or more of processes (i)-(iv); and

c) one or more computer processor modules programmed to execute the instructions,

d) wherein the one or more microfluidic units comprises a plurality of flow channels.

2. The system of claim 1 , wherein the system is further operable to perform an analysis of the isolated cells of (i), the expanded cells of (ii), the reprogrammed cells of (iii), or a combination thereof.

3. The system of claim 1 , wherein the one or more microfluidic units is further operable to differentiate the iPSC to produce a cell of a desired cell type.

4. The system of claim 3 , wherein the system is further operable to perform an analysis on the cell of the desired cell type.

5. The system of claim 3 , wherein the system is further operable to store the cell of the desired cell type.

6. The system of claim 1 , wherein storing cells comprises freezing the cells.

7. The system of claim 1 , further comprising a graphical user interface.

8. The system of claim 1 , wherein the microfluidic units are wirelessly or electrically coupled.

9. The system of claim 1 , wherein the microfluidic units are fluidly coupled.

10. The system of claim 1 , wherein the microfluidic units are disposed within a unitary housing.

11. The system of claim 1 , wherein the cells are stored on a microfluidic chip.

12. The system of claim 1 , wherein the system further comprises a storage unit for storing the cells at −80° C. or less.

13. The system of claim 1 , wherein the system is further operable to process and store sample data associated with stored cells.

14. The system of claim 1 , wherein cells are stored as master and working cell banks.

15. A method for processing a biological sample comprising: a) applying the sample to the system according to 1; and b) processing the sample with the system, the processing comprising: i) isolating cells from the sample; ii) expanding the isolated cells to produce a population of expanded cells; iii) reprogramming the isolated or expanded cells; and iv) storing cells from any of (i), (ii) or (iii), thereby processing the biological sample.

16. The method of claim 15 , further comprising differentiating the reprogrammed cells to produce a cell of a desired cell type.

17. The method of claim 16 , further comprising analyzing the isolated cells of (i), the expanded cells of (ii), the reprogrammed cells of (iii), the cell of a desired cell type, or a combination thereof.

18. A method of treating a disease or disorder in a subject comprising: a) obtaining a sample from the subject; b) applying the sample to the system according to claim 1 ; c) processing the sample with the system, the processing comprising: i) isolating cells from the sample; ii) expanding the isolated cells to produce a population of expanded cells; iii) reprogramming the isolated or expanded cells; iv) differentiating the reprogrammed cells to a desired cell type; and v) storing cells from any of (i), (ii), (iii) or (iv); and d) administering the subject a cell of any of (i)-(v), thereby treating the disease or disorder in the subject.

19. The method of claim 18 , further comprising analyzing the isolated cells of (i), the expanded cells of (ii), the reprogrammed cells of (iii), the cell of a desired cell type, or a combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2019
From: NOGGLE, SCOTT; CHANG, STEPHEN
To: NEW YORK STEM CELL FOUNDATION, INC.
Reel/Frame 050202/0643 →
Continuity (2)
Provisional Application 62424208 · Nov 18, 2016
Related Publication 20190316075A1 · Oct 17, 2019